Dr Martens stamps down profit guidance after warehouse headache
The shoe brand downgraded its outlook after taking about a £15 million hit from supply delays at its LA distribution centre.
Bootmaker Dr Martens has seen its sales step up but cut its profit expectations after forking out to tackle problems at its Los Angeles warehouse.
The shoe brand downgraded its outlook after taking about a £15 million hit from supply delays at the distribution centre.
It now expects to make about £245 million in earnings this financial year, which ended on March 31, due to higher costs and lower wholesale revenue.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.